Picture of Grail logo

GRAL Grail Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareMid CapNeutral

Annual income statement for Grail, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
2022
January 2nd
2023
December 31st
2023
January 1st
2024
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUSPROSPECTUSPROSPECTUS10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue014.693.155.5126
Cost of Revenue
Gross Profit3.0838.317.455.9
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses2561,2801,6085,4982,315
Operating Profit-256-1,265-1,515-5,443-2,189
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes-245-1,265-1,508-5,441-2,162
Provision for Income Taxes
Net Income After Taxes-245-1,248-1,466-5,399-2,027
Net Income Before Extraordinary Items
Net Income-245-1,248-1,466-5,399-2,027
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income-245-1,248-1,466-5,399-2,027
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS-9.19-37.8-37.2-88-33.8